AESKULISA® Glia-G 7502US

GUDID 04250289503112

AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for the quantitative and qualitative detection of IgG anti

Aesku.Diagnostics GmbH & Co. KG

Multiple Coeliac disease-associated antibody IVD, kit, enzyme immunoassay (EIA)

• Primary Device ID: 04250289503112
• NIH Device Record Key: 9ba34f95-a877-477d-a7e3-2898ac6471c5
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: AESKULISA® Glia-G
• Version Model Number: 7502US
• Catalog Number: 7502US
• Company DUNS: 341714388
• Company Name: Aesku.Diagnostics GmbH & Co. KG
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: false
• OTC Over-The-Counter: false

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	04250289503112 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Notification: K052439

FDA Product Code

• MST: Antibodies, Gliadin

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: Update
• Device Record Status: Published
• Public Version Number: 3
• Public Version Date: 2018-07-06
• Device Publish Date: 2017-03-17

On-Brand Devices [AESKULISA® Glia-G ]

• 04250289503112: AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for
• 04250289502863: AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for
• 04250289501491: AESKULISA Glia-G is a solid phase enzyme immunoassay employing highly purified alphaGliadin for